EA200200375A1 - Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку - Google Patents

Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку

Info

Publication number
EA200200375A1
EA200200375A1 EA200200375A EA200200375A EA200200375A1 EA 200200375 A1 EA200200375 A1 EA 200200375A1 EA 200200375 A EA200200375 A EA 200200375A EA 200200375 A EA200200375 A EA 200200375A EA 200200375 A1 EA200200375 A1 EA 200200375A1
Authority
EA
Eurasian Patent Office
Prior art keywords
intended
pharmaceutical composition
ciclesonide
cyclesonide
sledge
Prior art date
Application number
EA200200375A
Other languages
English (en)
Other versions
EA006015B1 (ru
Inventor
Атсухиро Нагано
Ёшихиса Нишибе
Казуя Таканаши
Original Assignee
Бык Гульден Ломберг Хемише Фабрик Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200200375(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бык Гульден Ломберг Хемише Фабрик Гмбх filed Critical Бык Гульден Ломберг Хемише Фабрик Гмбх
Publication of EA200200375A1 publication Critical patent/EA200200375A1/ru
Publication of EA006015B1 publication Critical patent/EA006015B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В заявке описана фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку, которую можно применять для фармакотерапии и которая включает водонерастворимое и/или мало растворимое в воде вещество, циклезонид и водную среду и имеет осмотическое давление менее 290 мО/см. Эта композиция обладает преимуществом по сравнению с общепринятыми фармацевтическими композициями, предназначенными для нанесения на слизистую оболочку, которое обусловлено эффективной и высокой способностью циклезонида удерживаться в слизистой оболочке и способностью циклезонида проникать в подслизистую основу и кровеносную систему слизистой оболочки.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200375A 1999-10-20 2000-10-20 Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку EA006015B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (2)

Publication Number Publication Date
EA200200375A1 true EA200200375A1 (ru) 2002-10-31
EA006015B1 EA006015B1 (ru) 2005-08-25

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200375A EA006015B1 (ru) 1999-10-20 2000-10-20 Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку

Country Status (36)

Country Link
US (1) US6767901B1 (ru)
EP (1) EP1225902B1 (ru)
JP (1) JP4264211B2 (ru)
KR (1) KR100722209B1 (ru)
CN (2) CN1379674B (ru)
AR (1) AR026072A1 (ru)
AT (1) ATE285779T1 (ru)
AU (1) AU781895B2 (ru)
BG (1) BG65818B1 (ru)
BR (1) BRPI0014878B8 (ru)
CA (1) CA2388322C (ru)
CO (1) CO5261494A1 (ru)
CZ (1) CZ297779B6 (ru)
DE (1) DE60017175T2 (ru)
DK (1) DK1225902T3 (ru)
EA (1) EA006015B1 (ru)
ES (1) ES2234681T3 (ru)
HK (2) HK1050858A1 (ru)
HR (1) HRP20020346B1 (ru)
HU (1) HU228893B1 (ru)
IL (2) IL148691A0 (ru)
ME (1) ME00567A (ru)
MX (1) MXPA02003974A (ru)
MY (1) MY136987A (ru)
NO (1) NO327444B1 (ru)
NZ (1) NZ518298A (ru)
PE (1) PE20010712A1 (ru)
PL (1) PL199702B1 (ru)
PT (1) PT1225902E (ru)
RS (1) RS50310B (ru)
SI (1) SI1225902T1 (ru)
SK (1) SK286196B6 (ru)
TR (1) TR200200841T2 (ru)
TW (1) TWI225788B (ru)
WO (1) WO2001028562A1 (ru)
ZA (1) ZA200203077B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
NZ537945A (en) * 2002-07-02 2007-08-31 Altana Pharma Ag Ciclesonide-containing sterile aqueous suspension
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
CN100509852C (zh) * 2002-07-26 2009-07-08 Fmc有限公司 微晶纤维素的制造
KR101067795B1 (ko) * 2002-08-30 2011-09-27 니코메드 게엠베하 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도
DK1572217T3 (da) * 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
US8371292B2 (en) * 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
JP2008512428A (ja) * 2004-09-10 2008-04-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング シクレソニドとＳｙｋインヒビターとの組合せ物並びにその使用方法
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
WO2009114192A2 (en) * 2008-03-14 2009-09-17 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (en) 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd SUSPENSION COLLYRE OF FLUOROMETHOLONE
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
BRPI0014878B8 (pt) 2021-05-25
PE20010712A1 (es) 2001-07-12
MXPA02003974A (es) 2003-09-25
CZ297779B6 (cs) 2007-03-28
ES2234681T3 (es) 2005-07-01
CN101869570A (zh) 2010-10-27
BR0014878A (pt) 2002-06-11
CZ20021238A3 (cs) 2002-07-17
BRPI0014878B1 (pt) 2015-08-11
EP1225902B1 (en) 2004-12-29
ME00567B (me) 2011-12-20
CA2388322A1 (en) 2001-04-26
DE60017175T2 (de) 2005-12-29
HU228893B1 (hu) 2013-06-28
TWI225788B (en) 2005-01-01
IL148691A (en) 2006-12-10
ZA200203077B (en) 2003-02-26
RS50310B (sr) 2009-09-08
IL148691A0 (en) 2002-09-12
KR100722209B1 (ko) 2007-05-29
PL356191A1 (en) 2004-06-14
TR200200841T2 (tr) 2002-07-22
DE60017175D1 (de) 2005-02-03
HK1149719A1 (en) 2011-10-14
SK286196B6 (sk) 2008-05-06
NZ518298A (en) 2003-11-28
NO20021898L (no) 2002-04-22
AU7953100A (en) 2001-04-30
YU28002A (sh) 2004-11-25
HUP0203339A2 (hu) 2003-02-28
BG106512A (bg) 2002-12-29
ATE285779T1 (de) 2005-01-15
SK6922002A3 (en) 2002-09-10
CN101869570B (zh) 2012-10-10
HRP20020346A2 (en) 2004-02-29
ME00567A (en) 2011-12-20
HK1050858A1 (zh) 2003-07-11
NO20021898D0 (no) 2002-04-22
JP2003512329A (ja) 2003-04-02
CO5261494A1 (es) 2003-03-31
WO2001028562A1 (en) 2001-04-26
CN1379674A (zh) 2002-11-13
DK1225902T3 (da) 2005-05-02
KR20020059627A (ko) 2002-07-13
AU781895B2 (en) 2005-06-23
HRP20020346B1 (en) 2011-06-30
MY136987A (en) 2008-12-31
AR026072A1 (es) 2002-12-26
JP4264211B2 (ja) 2009-05-13
SI1225902T1 (en) 2005-06-30
PT1225902E (pt) 2005-05-31
NO327444B1 (no) 2009-06-29
CN1379674B (zh) 2014-10-29
EA006015B1 (ru) 2005-08-25
PL199702B1 (pl) 2008-10-31
HUP0203339A3 (en) 2004-07-28
US6767901B1 (en) 2004-07-27
BG65818B1 (bg) 2010-01-29
EP1225902A1 (en) 2002-07-31
CA2388322C (en) 2007-09-18

Similar Documents

Publication Publication Date Title
EA200000060A1 (ru) Фармацевтические композиции для нанесения на слизистую оболочку
EA200200375A1 (ru) Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку
PT86536A (pt) Sistema terapeutico para ingredientes activos pouco soluveis
CA2274485A1 (en) Medicinal composition
NO970361L (no) Spraybart filmdannende system som frigjör aktive stoffer for anvendelse på planter
EP0985347A4 (en) EFFERVESCENT PREPARATION FOR PLANTS
CA2247107A1 (en) Releasant for aqueous polymer-type floor polish
JPS5540604A (en) Improved local topicum
BR0011864A (pt) Formulações farmacêuticas
FI118953B (fi) Ulkoisesti käytettävä, nimesulidia käsittävä tulehdusta torjuva aine
RU2001120110A (ru) Фармацевтическая смесь, содержащая профен
DE69617868D1 (de) Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol
FR2821552B1 (fr) Procede pour rendre hydrosoluble un principe actif naturellement peu ou pas soluble dans l'eau et ses utilisations
RU98102892A (ru) Состав основы для лекарственных пленок
RU97114385A (ru) Гиполипидемическое и гепатопротекторное средство
TH56262B (th) สารผสมทางเภสัชกรรมที่มีคลีโซไนด์สำหรับการใช้ที่เยื่อบุ
RU97113970A (ru) Гель для ухода за кожей лица
MY124416A (en) Pharmaceutical composition for application to mucosa
RU97114327A (ru) Антисептический препарат "лизанин оп"
RU98102386A (ru) Состав для очистки поверхности
KR920007620A (ko) 실리마린 및 약학 또는 화장품조성물의 용해방법
RU99107244A (ru) Лекарственная форма для фиксации съемных протезов
FR2809958B1 (fr) Composition pharmaceutique sous forme liquide destinee a l'administration par voie orale d'un principe actif, ayant un gout desagreable, notamment un gout amer
RU94002975A (ru) Препарат для массажа "малавит"
RU94001451A (ru) Препарат для массажа "малавит"

Legal Events

Date Code Title Description
PD1A Registration of transfer to a eurasian application by order of succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
TC4A Change in name of a patent proprietor in a eurasian patent
PC4A Registration of transfer of a eurasian patent by assignment
PC4A Registration of transfer of a eurasian patent by assignment
MK4A Patent expired

Designated state(s): BY RU